Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.
Procter & Gamble Hygiene & Healthcare Ltd reported revenue from operations of ₹891.5 Cr (-4.9% YoY) and net profit of ₹126.3 Cr (-34.3% YoY) for Q1 FY27.
P&G Hygiene reported FY26 sales of ₹4300cr (flat YoY) and PAT of ₹850cr (up 19%). Strategy focuses on 'irresistible superiority' in Feminine Care and Healthcare through innovation and productivity.
Procter & Gamble Hygiene and Health Care Ltd reported FY 2025-26 results showing flat sales growth and a 19% increase in Profit After Tax (PAT), focusing on productivity and brand superiority.
Procter & Gamble Hygiene & Healthcare Ltd reported revenue from operations of ₹941.3 Cr (-5.1% YoY) and net profit of ₹153.1 Cr (-1.9% YoY) for Q4 FY26.